MRC Highlight Notice: Researching ME/CFS
Closing Date: –
Support for high-quality funding applications in ME/CFS research to any of the MRC’s grants from MRC research boards or MRC fellowships.
The Medical Research Council (MRC) operates the Researching ME/CFS highlight notice to enable applicants to research myalgic encephalomyelitis/chronic fatigue syndrome, also known as ME/CFS.
Applicants can access funding either through:
- Grants from MRC research boards; or
- MRC fellowships
Proposals are particularly sought that lie within MRC remit and address one or more of the following research areas identified by the 2022 ME/CFS Priority Setting Partnership for ME/CFS research:
- Post-exertional malaise.
- Use of existing drugs for other conditions.
- Diagnosis.
- Autoimmunity.
- ME/CFS sub-types.
- Post-infective cause.
- Neurological symptomology.
- Genetics.
- Severe ME/CFS.
- Mitochondrial dysfunction.
- Oxygenation dysfunction.
Research proposals should consider how to:
- Increase capacity in ME/CFS research.
- Address the need for multidisciplinary teams to tackle the significant research challenges in this area.
- Involve persons living with ME/CFS in developing ME/CFS research proposals.
Research proposals may involve partnerships between ME/CFS researchers and established, leading investigators working in relevant areas, but who are new to the ME/CFS field.
Funding body | Medical Research Council (MRC) |
---|---|
Maximum value | Discretionary |
Reference ID | S25555 |
Category | Medical Research |
Fund or call | Fund |